Bharat Biotech to produce 1 billion doses of Covaxin annually at four facilities

Bharat Biotech said it will utilise the Ankleshwar-based production facility of its wholly-owned subsidiary Chiron Behring Vaccines to add another 200 million doses of Covaxin